Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Agenus Inc.

Clinical trials sponsored by Agenus Inc., explained in plain language.

Agenus Inc. AGEN NASDAQ

A biotech developing immunotherapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 3 Completed 3 Terminated 1

Immunotherapy combo shows promise for advanced cervical cancer

Disease control Terminated

This phase 2 trial tested two immunotherapy drugs, AGEN2034 and AGEN1884, in 211 women with recurrent cervical cancer that had progressed after chemotherapy. One group received AGEN2034 alone, the other received both drugs. The goal was to see if the tumors shrank. The study was …

Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC